Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
This study has been completed.
Study NCT00005023 Information provided by National Cancer Institute (NCI)
First Received: April 6, 2000 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Lung Cancer
Ovarian Cancer
Additional conditions recognized in this trial
Breast Neoplasms
Lung Neoplasms
Ovarian Neoplasms
More general conditions related to this trial
Adnexal Diseases
Breast Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Lung Diseases
Neoplasms
Neoplasms by Site
Ovarian Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Skin Diseases
Thoracic Neoplasms
Urogenital Neoplasms
Interventions listed in this trial
HER-2/neu peptide vaccine
sargramostim
Sponsors listed in this trial
University of Washington
Back to top of Main Content
